Skip to main content

Advertisement

Fig. 3 | Cancer Communications

Fig. 3

From: Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations

Fig. 3

Kaplan-Meier curves of the progression-free survival (PFS) and overall survival (OS) for mutant-EGFR NSCLC patients with aberrations in PTEN and MET genes. PFS (a) and OS (b) were analyzed in the 169 EGFR-mutant NSCLC patients, according to PTEN copy number alterations. In the subgroups of EGFR-mutant NSCLC patients with MET FISH status, PFS (c) and OS (d) were analyzed. The survival rates were compared using the log-rank test

Back to article page